Overview
Background
Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, a unique resource located on the Queensland Children's Hospital precinct, facilitating local, national and international collaborative research across all childhood cancer types and supporting enrolment of children on clinical trials. A/Prof. Moore's clinical and research interests focus on childhood leukaemia, particularly acute myeloid leukaemia (AML), an aggressive form of leukaemia with a poor prognosis. He also holds a number of leadership and advisory roles, including Deputy Chair of the Australian & New Zealand Childrens Haematology / Oncology Group (ANZCHOG).
Availability
- Dr Andy Moore is:
- Not available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
- Doctor of Philosophy, University College London
Research interests
-
Acute Myeloid Leukaemia
-
Leukaemia
-
Blood Cancers
-
Paediatric Oncology
-
Childhood Cancer
-
Biobanking
Works
Search Professor Andy Moore’s works on UQ eSpace
2024
Journal Article
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
Neller, Michelle A., Ambalathingal, George R., Hamad, Nada, Sasadeusz, Joe, Pearson, Rebecca, Holmes-Liew, Chien-Li, Singhal, Deepak, Tunbridge, Matthew, Ng, Wei Yang, Sharplin, Kirsty, Moore, Andrew, Deambrosis, David, Soosay-Raj, Trisha, McNaughton, Peter, Whyte, Morag, Fraser, Chris, Grigg, Andrew, Kliman, David, Bajel, Ashish, Cummins, Katherine, Dowling, Mark, Yeoh, Zhi Han, Harrison, Simon J., Khot, Amit, Tan, Sarah, Roos, Izanne, Koo, Ray Mun, Dohrmann, Sara, Ritchie, David ... Khanna, Rajiv (2024). Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years. Nature Communications, 15 (1) 10339, 1-12. doi: 10.1038/s41467-024-54595-2
2024
Journal Article
Population‐level 5‐year event‐free survival for children with cancer in Australia
Youlden, Danny R., Baade, Peter D., Gottardo, Nicolas G., Moore, Andrew S., Valery, Patricia C. and Pole, Jason D. (2024). Population‐level 5‐year event‐free survival for children with cancer in Australia. Pediatric Blood and Cancer, 71 (10) e31195, 1-11. doi: 10.1002/pbc.31195
2024
Journal Article
Invasive fungal disease in children with solid tumors: an Australian multicenter 10‐year review
Jain, Neha, Ryan, Anne L., Haeusler, Gabrielle M., McMullan, Brendan J., Moore, Andrew S., Bartlett, Adam W., Blyth, Christopher C., Kotecha, Rishi S., Yeoh, Daniel K. and Clark, Julia E. (2024). Invasive fungal disease in children with solid tumors: an Australian multicenter 10‐year review. Pediatric Blood & Cancer, 71 (7) e31031, e31031. doi: 10.1002/pbc.31031
2024
Journal Article
Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial)
Ullman, Amanda, Takashima, Mari, Gibson, Victoria, Comber, Elouise, Borello, Eloise, Bradford, Natalie, Byrnes, Joshua, Cole, Roni, Eisenstat, David, Henson, Nicole, Howard, Philippa, Irwin, Adam, Keogh, Samantha, Kleidon, Tricia, Martin, Michelle, McCleary, Karen, McLean, Jordana, Moloney, Susan, Monagle, Paul, Moore, Andrew, Newall, Fiona, Noyes, Michelle, Rowan, Gemma, St John, Amanda, Wood, Andrew, Wolf, Joshua and Ware, Robert (2024). Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial). BMJ Open, 14 (7) e085637, 1-9. doi: 10.1136/bmjopen-2024-085637
2024
Journal Article
Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk
Kimura, Shunsuke, Park, Chun Shik, Montefiori, Lindsey E., Iacobucci, Ilaria, Polonen, Petri, Gao, Qingsong, Arnold, Elizabeth D., Attarbaschi, Andishe, Brown, Anthony, Buldini, Barbara, Caldwell, Kenneth J., Chang, Yunchao, Chen, Chelsey, Cheng, Cheng, Cheng, Zhongshan, Choi, John, Conter, Valentino, Crews, Kristine R., de Groot-Kruseman, Hester A., Deguchi, Takao, Eguchi, Mariko, Muhle, Hannah Elisa., Elitzur, Sarah, Escherich, Gabriele, Freeman, Burgess B., Gu, Zhaohui, Han, Katie, Horibe, Keizo, Imamura, Toshihiko ... Mullighan, Charles G. (2024). Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer Discovery, 14 (10), 1838-1859. doi: 10.1158/2159-8290.cd-23-1452
2024
Journal Article
Precision-guided treatment in high-risk pediatric cancers
Lau, Loretta M. S., Khuong-Quang, Dong-Anh, Mayoh, Chelsea, Wong, Marie, Barahona, Paulette, Ajuyah, Pamela, Senapati, Akanksha, Nagabushan, Sumanth, Sherstyuk, Alexandra, Altekoester, Ann-Kristin, Fuentes-Bolanos, Noemi A., Yeung, Veronica, Sullivan, Ashleigh, Omer, Natacha, Diamond, Yonatan, Jessop, Sophie, Battaglia, Lauren, Zhukova, Nataliya, Cui, Louise, Lin, Angela, Gifford, Andrew J., Fleuren, Emmy D. G., Dalla-Pozza, Luciano, Moore, Andrew S., Khaw, Seong-Lin, Eisenstat, David D., Gottardo, Nicholas G., Wood, Paul J., Tapp, Heather ... Ziegler, David S. (2024). Precision-guided treatment in high-risk pediatric cancers. Nature Medicine, 30 (7), 1913-1922. doi: 10.1038/s41591-024-03044-0
2024
Journal Article
Incidence and survival for childhood cancer by endorsed non‐stage prognostic indicators in Australia
Youlden, Danny R., Gupta, Sumit, Frazier, A. Lindsay, Moore, Andrew S., Gottardo, Nicholas G. and Aitken, Joanne F. (2024). Incidence and survival for childhood cancer by endorsed non‐stage prognostic indicators in Australia. Pediatric Blood and Cancer, 71 (4) e30889, e30889. doi: 10.1002/pbc.30889
2024
Journal Article
Characterization of human engraftment and hemophagocytic lymphohistiocytosis in NSG-SGM3 neonate mice engrafted with purified CD34+ hematopoietic stem cells
Liam, O'Brien, Carina, Walpole, Leal-Rojas, Ingrid M., Svetlana, Shatunova, Andrew, Moore, Winkler, Ingrid G, Camille, Guillerey and Radford, Kristen J. (2024). Characterization of human engraftment and hemophagocytic lymphohistiocytosis in NSG-SGM3 neonate mice engrafted with purified CD34+ hematopoietic stem cells. Experimental Hematology, 130 104134, 104134. doi: 10.1016/j.exphem.2023.11.008
2024
Journal Article
Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis
Tu, Cui, Buckle, Irina, Leal Rojas, Ingrid, Rodrigues Rossi, Gustavo, Sester, David P., Moore, Andrew S., Radford, Kristen, Guillerey, Camille and Souza‐Fonseca‐Guimaraes, Fernando (2024). Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis. Clinical and Translational Immunology, 13 (3) e1501, 1-15. doi: 10.1002/cti2.1501
2023
Journal Article
Providing Australian children and adolescents with equitable access to new and emerging therapies through clinical trials: a call to action
Lorentzos, Michelle S., Metz, David, Moore, Andrew S., Fawcett, Laura K., Bray, Paula, Attwood, Lani, Munns, Craig F. and Davidson, Andrew (2023). Providing Australian children and adolescents with equitable access to new and emerging therapies through clinical trials: a call to action. Medical Journal of Australia, 220 (3), 121-125. doi: 10.5694/mja2.52191
2023
Journal Article
Late effects in survivors of infant acute lymphoblastic leukaemia—a study of the Australian and New Zealand Children’s Haematology/Oncology Group
Mironova, Denitza, Saraswati, Chitra M., Downie, Peter, Lai, Chow Yee, Cook, Eleanor, Carruthers, Vickyanne, Moukhaiber, Perla, Molloy, Fiona, Serov, Joshua, McKinnon, Elizabeth, Alvaro, Frank, Osborn, Michael, Revesz, Tamas, Prestidge, Tim, Cross, Siobhan, Bateman, Caroline M., Moore, Andrew S., Khaw, Seong Lin, Mateos, Marion K. and Kotecha, Rishi S. (2023). Late effects in survivors of infant acute lymphoblastic leukaemia—a study of the Australian and New Zealand Children’s Haematology/Oncology Group. Blood Cancer Journal, 13 (1) 150, 150. doi: 10.1038/s41408-023-00924-5
2023
Journal Article
Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive KMT2A fluorescence in situ hybridization result
Nunn, Jenna, Adayapalam, Nandini, Riyat, Sarbjit, Seymour, Louise, Williams, Bronwyn, Rehn, Jacqueline, White, Deborah, Moore, Andrew S. and Tsuchiya, Karen (2023). Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive KMT2A fluorescence in situ hybridization result. Cancer Genetics, 278-279, 80-83. doi: 10.1016/j.cancergen.2023.09.002
2023
Journal Article
Reproducible bioinformatics analysis workflows for detecting IGH gene fusions in B-cell acute lymphoblastic leukaemia patients
Thomson, Ashlee J., Rehn, Jacqueline A., Heatley, Susan L., Eadie, Laura N., Page, Elyse C., Schutz, Caitlin, McClure, Barbara J., Sutton, Rosemary, Dalla-Pozza, Luciano, Moore, Andrew S., Greenwood, Matthew, Kotecha, Rishi S., Fong, Chun Y., Yong, Agnes S. M., Yeung, David T., Breen, James and White, Deborah L. (2023). Reproducible bioinformatics analysis workflows for detecting IGH gene fusions in B-cell acute lymphoblastic leukaemia patients. Cancers, 15 (19) 4731, 1-13. doi: 10.3390/cancers15194731
2023
Conference Publication
A High-grade Gliomas Occurring In Teenagers And Young Adult Patients Comprise Novel Molecular Subgroups
Clarke, M. T., Pereira, R., Mackay, A., Grabovska, Y., Clarke, A., Nicoll, J., Procter, J., Moore, A., Schagen, J., Walker, L., Roncaroli, F., Ogunbigi, O., Jacques, T., Marshall, L., Carceller, F., Reisz, Z., Al-Sarraj, S., Vinci, M., Kurian, K., Ng, H., Brandner, S. and Jones, C. (2023). A High-grade Gliomas Occurring In Teenagers And Young Adult Patients Comprise Novel Molecular Subgroups. 18th Meeting of the European Association of Neuro-Oncology, Rotterdam, Netherlands, 21-24 September 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/neuonc/noad137.069
2023
Journal Article
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–2017
Youlden, Danny R., Baade, Peter D., Frazier, A. Lindsay, Gupta, Sumit, Gottardo, Nicolas G., Moore, Andrew S. and Aitken, Joanne F. (2023). Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–2017. Acta Oncologica, 62 (10), 1256-1264. doi: 10.1080/0284186X.2023.2251668
2023
Journal Article
Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia
Conn, Vanessa M., Gabryelska, Marta, Toubia, John, Kirk, Kirsty, Gantley, Laura, Powell, Jason A., Cildir, Gökhan, Marri, Shashikanth, Liu, Ryan, Stringer, Brett W., Townley, Scott, Webb, Stuart T., Lin, He, Samaraweera, Saumya E., Bailey, Sheree, Moore, Andrew S., Maybury, Mellissa, Liu, Dawei, Colella, Alex D., Chataway, Timothy, Wallington-Gates, Craig T., Walters, Lucie, Sibbons, Jane, Selth, Luke A., Tergaonkar, Vinay, D’Andrea, Richard J., Pitson, Stuart M., Goodall, Gregory J. and Conn, Simon J. (2023). Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia. Cancer Cell, 41 (7), 1309-1326.e10. doi: 10.1016/j.ccell.2023.05.002
2023
Conference Publication
High-grade gliomas occurring in teenagers and young adult patients comprise novel molecular subgroups
Clarke, Matthew, Pereira, Rita, Mackay, Alan, Grabovska, Yura, Clarke, Amelia, Nicoll, James, Procter, John, Moore, Andrew, Schagen, Joanna, Walker, Liam, Roncaroli, Federico, Ogunbigi, Olumide, Jacques, Thomas, Marshall, Lynley, Carceller, Fernando, Reisz, Zita, Al-Sarraj, Safa, Vinci, Maria, Kurian, Kathreena, Ng, H K, Brandner, Sebastian and Jones, Chris (2023). High-grade gliomas occurring in teenagers and young adult patients comprise novel molecular subgroups. 2023 Pediatric Neuro-Oncology Research Conference, Washington, DC United States, 22-24 June 2023. Cary, NC United States: Oxford University Press. doi: 10.1093/neuonc/noad073.164
2023
Journal Article
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Mayoh, Chelsea, Gifford, Andrew J., Terry, Rachael, Lau, Loretta M S, Wong, Marie, Rao, Padmashree, Shai-Hee, Tyler, Saletta, Federica, Khuong-Quang, Dong-Anh, Qin, Vicky, Mateos, Marion K., Meyran, Deborah, Miller, Katherine E., Yuksel, Aysen, Mould, Emily V A, Bowen-James, Rachel, Govender, Dinisha, Senapati, Akanksha, Zhukova, Nataliya, Omer, Natacha, Dholaria, Hetal, Alvaro, Frank, Tapp, Heather, Diamond, Yonatan, Pozza, Luciano Dalla, Moore, Andrew S., Nicholls, Wayne, Gottardo, Nicholas G., McCowage, Geoffrey ... Ekert, Paul G. (2023). A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer. Genome Medicine, 15 (1) 20, 20. doi: 10.1186/s13073-023-01170-x
2022
Journal Article
Childhood cancer survival and avoided deaths in Australia, 1983–2016
Youlden, Danny R., Baade, Peter D., Moore, Andrew S., Pole, Jason D., Valery, Patricia C. and Aitken, Joanne F. (2022). Childhood cancer survival and avoided deaths in Australia, 1983–2016. Paediatric and Perinatal Epidemiology, 37 (1), 81-91. doi: 10.1111/ppe.12895
2022
Journal Article
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
Venn, Nicola C., Huang, Libby, Hovorková, Lenka, Muskovic, Walter, Wong, Marie, Law, Tamara, Heatley, Susan L., Khaw, Seong Lin, Revesz, Tom, Dalla Pozza, Luciano, Shaw, Peter J., Fraser, Chris, Moore, Andrew S., Cross, Siobhan, Bendak, Katerina, Norris, Murray D., Henderson, Michelle J., White, Deborah L., Cowley, Mark J., Trahair, Toby N., Zuna, Jan and Sutton, Rosemary (2022). Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions. British Journal of Cancer, 127 (5), 908-915. doi: 10.1038/s41416-022-01806-6
Funding
Current funding
Past funding
Supervision
Availability
- Dr Andy Moore is:
- Not available for supervision
Supervision history
Completed supervision
-
2020
Doctor Philosophy
Characterisation of the MLL fusion transcriptome in childhood leukaemia
Principal Advisor
-
Doctor Philosophy
Aminopeptidase Inhibition as a Potential Therapeutic Strategy for Acute Myeloid Leukaemia
Principal Advisor
Media
Enquiries
Contact Dr Andy Moore directly for media enquiries about:
- Childhood Cancer
- Childhood Leukaemia
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: